Orchestra BioMed (OBIO) Misses Q3 EPS by 40c

Orchestra BioMed (NASDAQ: OBIO) reported Q3 EPS of ($0.40). Revenue for the quarter came in at $900 thousand.

For earnings history and earnings-related data on Orchestra BioMed (OBIO) click here.

You May Also Be Interested In

• Deutsche Bank Upgrades PennyMac Mortgage Investment Trust (PMT) to Buy
• Jefferies Downgrades BSE Limited (BSE:IN) to Underperform
• ICICI Securities Starts Cemindia Projects (CEMPRO:IN) at Buy (1)